Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

Lili Li1, Chen Li1, Haitao Mao1

  • 1Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.

Scientific Reports
|May 27, 2016
PubMed

Insights

TET1, a crucial gene demethylase, is frequently silenced by methylation in various cancers, acting as a tumor suppressor by reactivating silenced tumor suppressor genes.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Promoter CpG methylation regulates gene expression.
  • TET proteins are CpG demethylases; loss of 5-hydroxymethylcytosine (5hmC) is an epigenetic hallmark of cancer.
  • TET proteins play critical roles in epigenetic tumorigenesis.

Purpose of the Study:

  • To investigate TET1 as a potential tumor suppressor in various cancers.
  • To identify the mechanism of TET1 inactivation in tumorigenesis.
  • To explore the therapeutic potential of TET1 in cancer treatment.

Main Methods:

  • Analysis of tumor methylomes to identify TET1 as a methylated target.
  • Confirmation of TET1 downregulation/methylation in cancer cell lines and primary tumors.
  • Ectopic expression of TET1 catalytic domain in tumor cells.
  • Assessment of TET1 demethylase activity in cancer cells and its effect on tumor suppressor gene promoters.

Main Results:

  • TET1 was found to be frequently downregulated and methylated in multiple carcinomas and lymphomas.
  • Ectopic expression of TET1 suppressed tumor cell growth and induced apoptosis.
  • TET1 catalytic domain exhibited demethylase activity, inhibiting CpG methylation of tumor suppressor gene promoters (e.g., SLIT2, ZNF382, HOXA9) and reactivating their expression.
  • Epigenetic silencing, not mutation, is the dominant mechanism for TET1 inactivation in cancers.

Conclusions:

  • TET1 functions as a broad tumor suppressor across various cancer types.
  • Epigenetic silencing of TET1 contributes to tumorigenesis by promoting CpG methylation.
  • TET1 inactivation creates a feedback loop of CpG methylation during cancer development.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
38.6K